X. Cynthia

CDK4/6 inhibition triggers anti-tumour immunity

Shom Goel, Molly J. DeCristo, April C. Watt et al. · Nature · 2017 · 1.5K citations · Full text

Medicine, Cancer Biology, Oncology +12

Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer

Ron Bose, Shyam M. Kavuri, Adam C. Searleman et al. · Cancer Discovery · 2012 · 880 citations

Medicine, Genetics, Oncology +17

TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer

Lisa A. Carey, Hope S. Rugo, P. Kelly Marcom et al. · Journal of Clinical Oncology · 2012 · 493 citations · Full text

Medicine, Oncology, Pharmacology +17

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)

Matthew J. Ellis, Vera J. Suman, Jeremy Hoog et al. · Journal of Clinical Oncology · 2017 · 411 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor–Positive Breast Cancer

X. Cynthia, Feng Gao, Jingqin Luo et al. · Clinical Cancer Research · 2017 · 376 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17